Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

New Drug Combo Fights High Blood Pressure


Related Encyclopedia
 border=
Alzheimer's Disease
Aneurysms
Angina Pectoris
Angiogram
More...

Related Healthscout Videos
 border=
Importance of Good Nutrition
Controlling Incontinence
Preventing Heart Disease the Easy Way
Lifestyle Changes for Heart Disease Prevention and Treatment
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Angioplasty
Animation: What is Hypertension?
Coronary Bypass Surgery
More...

Related Drug Information
 border=
Accupril
Actonel
Altace
Avapro
More...

Related News Articles
 border=
Beta Blockers Help Hospitalized Heart Failure Patients
Health Tip: Monitoring What You Drink
Aging Brain Can Learn New Tricks
Melanoma Drug Boosts Recurrence-Free Survival
More...


Page:  << Prev | 1 | 2

Blood pressure was reduced by an average of 12.2 points in those getting the higher doses of combined therapy, compared to a 9-point reduction for those getting Tekturna alone, a 9.7-point reduction for those getting Diovan alone, and 4.1 points for those taking placebo.

"These findings provide a clear rationale for further studies to investigate the potential effects of long-term treatment with the combination of aliskiren and valsartan, and combinations of aliskiren and other angiotensin receptor blockers, on possible benefits beyond treating hypertension," the journal report said.

A number of such studies using a variety of medications are under way, Oparil said.

Text Continues Below



However, an accompanying editorial raised serious doubts about the safety of the two-drug combination used in the study. The editorial noted that there was a sharp spike in blood potassium levels among some patients getting the combined therapy. This type of spike can cause "potentially life-threatening side effects" such as paralysis and cardiac arrest, the article's authors wrote.

"If this is given to patients, serum potassium levels should be monitored from the start," added Dr. Jan Staessen, professor of medicine at the University of Leuven, Belgium, co-author of the editorial. "This is a major limitation on its use."

Because of the need to monitor potassium levels, use of the two-drug therapy should be limited to "patients who already have complications and require special therapy but not in the majority of patients," Staessen said.

Oparil described that criticism as "inflammatory and unfair."

"They just wanted to paint the drugs in an unfavorable light," she said.

Data in the published report showed that the incidence of high blood potassium levels was as common in participants getting the placebo as those receiving the two-drug combination, Oparil said. And of 18 participants who had potassium readings higher than the danger level, "12 were normal on retest," she said.

More information

You can learn about the different drugs used for high blood pressure and how they act from the American Heart Association.

Page:  << Prev | 1 | 2

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 7/20/2007

Related Links
 border=
From Healthscout's partner site on high blood pressure, HighBloodPressureConnection.com
Learn more about high blood pressure symptoms.
Have high blood pressure? Learn about blood pressure medications.
Ways to lower blood pressure





New Features

New ADHD Site!

SOURCES: Suzanne Oparil, M.D., director, vascular biology and hypertensive program, University of Birmingham, Ala; Jan Staessen, M.D., professor of medicine, University of Leuven, Belgium; July 21, 2007, The Lancet


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map